secwatch.observer — SEC 8-K summary
======================================

Issuer:     COGNITION THERAPEUTICS INC (CGTX)
CIK:        0001455365
Form:       8-K
Filed at:   2024-09-13T23:59:59+00:00
Accession:  0001104659-24-099746
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Cognition Therapeutics receives Nasdaq deficiency notice for bid price below $1.00
--------------------------------------------------------------------------------

- Deficiency letter received on September 12, 2024; stock continues trading under CGTX.
- Company has until March 11, 2025 to regain compliance under Nasdaq Rule 5450(a)(1).
- If noncompliant, company may get second 180-day cure period upon transfer to Nasdaq Capital Market.
- No assurance of regaining compliance; delisting could occur if not cured.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1455365/000110465924099746/0001104659-24-099746-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1455365/000110465924099746/tm2424030d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-099746

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer